Compounds > 2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate
Page last updated: 2024-10-21

2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate and Nephrosis

2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate has been researched along with Nephrosis in 1 studies

2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate: inhibits phospholipase C and serine esterases; structure in first source

Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takenaka, T1
Suzuki, H1
Fujiwara, K1
Kanno, Y1
Ohno, Y1
Hayashi, K1
Nagahama, T1
Saruta, T1

Other Studies

1 other study available for 2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate and Nephrosis

ArticleYear
Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.
    The Journal of clinical investigation, 1997, Oct-15, Volume: 100, Issue:8

    Topics: Angiotensin II; Animals; Arterioles; Calcium; Calcium Channel Blockers; Calcium Channels; Carbamates

1997